Press release
Deadline on July 20th coming up ion Lawsuit for Investors in Provention Bio, Inc. (NASDAQ: PRVB)
A Deadline is coming up on July 20, 2021 in the lawsuit for certain investors in Provention Bio, Inc. (NASDAQ: PRVB).
Investors who purchased shares of Provention Bio, Inc. (NASDAQ: PRVB) have certain options and there are strict and short deadlines running. Deadline: July 20, 2021. NASDAQ: PRVB stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
According to the complaint filed in the U.S. District Court for the District of New Jersey the plaintiff alleges on behalf of purchasers of Provention Bio, Inc. (NASDAQ: PRVB) common shares between November 2, 2020 and April 8, 2021, that the defendants violated Federal Securities Laws. More specifically, the plaintiff claims that between November 2, 2020 and April 8, 2021, the defendants made false and/or misleading statements and/or failed to disclose that the teplizumab BLA was deficient in its submitted form and would require additional data to secure FDA approval, that accordingly, the teplizumab BLA lacked the evidentiary support the Company had led investors to believe it possessed, that the Company had thus overstated the teplizumab BLA's approval prospects and hence the commercialization timeline for teplizumab, and that as a result, the Company's public statements were materially false and misleading at all relevant times.
Those who purchased shares of Provention Bio, Inc. (NASDAQ: PRVB) have certain options and should contact the Shareholders Foundation.
Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Deadline on July 20th coming up ion Lawsuit for Investors in Provention Bio, Inc. (NASDAQ: PRVB) here
News-ID: 2317028 • Views: …
More Releases from Shareholders Foundation
ALERT: Lawsuit filed for Investors who SOLD shares of Sina Corporation (formerly …
An investor, who sold shares of Sina Corporation (formerly NASDAQ: SINA) in the merger between Seina Corporation and TuSimple Holdings, Inc, filed a lawsuit over alleged violations of Federal Securities Laws by Sina Corporation (formerly NASDAQ: SINA in connection with certain allegedly false and misleading statements made.
If you sold a significant amount of shares of Sina Corporation (formerly NASDAQ: SINA) between October 13, 2020 and March 22, 2021, you have…
Lawsuit Alert: Investors who lost money with shares of Fluor Corporation (NYSE: …
An investor, who purchased shares of Fluor Corporation (NYSE: FLR), filed a lawsuit alleged violations of Federal Securities Laws by Fluor Corporation in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Fluor Corporation (NYSE: FLR) have certain options and for certain investors are short and strict deadlines running. Deadline: November 14, 2025. NYSE: FLR investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779…
Investigation announced for Long-Term Investors in shares of Sable Offshore Corp …
An investigation was announced for long-term investors in shares of Sable Offshore Corp. (NYSE: SOC) concerning potential breaches of fiduciary duties by certain directors of Sable Offshore Corp.
Investors who are current long term investors in Sable Offshore Corp. (NYSE: SOC) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in…
Lawsuit filed for Investors who lost money with shares of Lantheus Holdings, Inc …
An investor, who purchased shares of Lantheus Holdings, Inc. (NASDAQ: LNTH), filed a lawsuit over alleged violations of Federal Securities Laws by Lantheus Holdings, Inc. in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Lantheus Holdings, Inc. (NASDAQ: LNTH) have certain options and for certain investors are short and strict deadlines running. Deadline: November 10, 2025. NASDAQ: LNTH investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com…
More Releases for Provention
Bispecific Antibody Competitive Landscape Report 2025 | Janssen, Amgen, Akeso, Z …
DelveInsight's, "Bispecific antibody - Competitive landscape, 2025," report provides comprehensive insights about 180+ companies and 250+ drugs in Bispecific antibody Competitive landscape. It covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key Takeaways from the Bispecific Antibody Competitive Landscape Report
• DelveInsight's Bispecific Antibody report depicts a robust space with 180+ active players working to develop 250+…
Gluten Sensitivity Market to Rise by 2032 | 9 Meters Biopharma, ImmunogenX, Prov …
DelveInsight's "Gluten Sensitivity Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Gluten Sensitivity, historical and forecasted epidemiology as well as the Gluten Sensitivity market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan.
The Gluten Sensitivity market report provides current treatment practices, emerging drugs, the market share of the individual therapies, and the current and forecasted Gluten Sensitivity market size…
Bispecific Antibody Competitive Landscape Report 2024 (Updated) | Janssen, Amgen …
DelveInsight's, "Bispecific antibody Competitive landscape 2024" report provides comprehensive insights about 250+ Bispecific Antibody companies and 300+ Bispecific Antibody drugs in Bispecific antibody Competitive landscape. It covers the Bispecific Antibody therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key Takeaways from the Bispecific Antibody Competitive Landscape Report
• DelveInsight's Bispecific Antibody report depicts a robust space with 250+…
Bispecific Antibody Competitive Landscape Report (Updated) | Janssen, Amgen, Ake …
DelveInsight's, "Bispecific antibody Competitive landscape" report provides comprehensive insights about 250+ Bispecific Antibody companies and 300+ Bispecific Antibody drugs in Bispecific antibody Competitive landscape. It covers the Bispecific Antibody therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key Takeaways from the Bispecific Antibody Competitive Landscape Report
• DelveInsight's Bispecific Antibody report depicts a robust space with 250+ active…
Gluten Sensitivity Market to Witness Growth by 2032 | 9 Meters Biopharma, Immuno …
DelveInsight's "Gluten Sensitivity Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Gluten Sensitivity, historical and forecasted epidemiology as well as the Gluten Sensitivity market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan.
The Gluten Sensitivity market report provides current treatment practices, emerging drugs, the market share of the individual therapies, and the current and forecasted Gluten Sensitivity market size…
Investigation announced for Long-Term Investors in Provention Bio, Inc. (NASDAQ: …
An investigation was announced concerning potential breaches of fiduciary duties by certain directors and officers of Provention Bio, Inc..
Investors who are current long term investors in Provention Bio, Inc. (NASDAQ: PRVB) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in NASDAQ: PRVB stocks follows a lawsuit filed against Provention…
